Company Filing History:
Years Active: 2014
Title: Innovations by Anders Westermark in the Treatment of Oral Mucositis
Introduction
Anders Westermark is a notable inventor based in Mariehamn, Aland, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of oral mucositis. His innovative approach involves the use of an ionic complex of chitosan and negatively charged polysaccharides.
Latest Patents
Westermark holds a patent for a composition that treats oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide. This composition is specifically designed for topical application and includes components such as heparin, heparan sulfate, and dextran sulfate. The patent outlines methods for preventing or treating mucositis in mammalian subjects, showcasing the potential of this treatment in clinical settings.
Career Highlights
Anders Westermark is associated with Exthera AB, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on improving patient outcomes through advanced treatment options.
Collaborations
Westermark has collaborated with notable colleagues, including Lars Adolfsson and Olle Larm. These partnerships have contributed to the advancement of his research and the development of effective treatments.
Conclusion
Anders Westermark's contributions to the treatment of oral mucositis highlight the importance of innovation in pharmaceuticals. His patented work demonstrates a commitment to improving healthcare solutions for patients.